Myriad Genetics Inc (NASDAQ:MYGN)

25.61
Delayed Data
As of Dec 06
 -0.06 / -0.23%
Today’s Change
20.10
Today|||52-Week Range
48.40
-11.90%
Year-to-Date
No recent news for Myriad Genetics Inc.

Today’s Trading

Previous close25.67
Today’s open25.94
Day’s range25.32 - 26.24
Volume497,802
Average volume (3 months)1,358,569
Market cap$1.9B
Data as of 4:00pm ET, 12/06/2019

Growth & Valuation

Earnings growth (last year)-96.69%
Earnings growth (this year)-37.80%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+10.16%
P/E ratioNM
Price/Sales2.48
Price/Book1.74

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc-0.81-2.70%
--Quidel Corp0.000.00%
CDNACareDx Inc+0.34+1.63%
AXDXAccelerate Diagnosti...+0.36+2.32%
Data as of 4:00pm ET, 12/06/2019

Financials

Next reporting dateFebruary 11, 2020
EPS forecast (this quarter)$0.31
Annual revenue (last year)$851.1M
Annual profit (last year)$4.6M
Net profit margin0.54%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Salt Lake City, Utah

Forecasts